|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Filho AM, Laversanne M, Ferlay J, Colombet
M, Piñeros M, Znaor A, Parkin DM, Soerjomataram I and Bray F: The
GLOBOCAN 2022 cancer estimates: Data sources, methods, and a
snapshot of the cancer burden worldwide. Int J Cancer.
156:1336–1346. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han B, Zheng R, Zeng H, Wang S, Sun K,
Chen R, Li L, Wei W and He J: Cancer incidence and mortality in
China, 2022. J Natl Cancer Cent. 4:47–53. 2024.PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33.
2021.PubMed/NCBI
|
|
5
|
Koskas M, Amant F, Mirza MR and Creutzberg
CL: Cancer of the corpus uteri:2021 update. Int J Gynaecol Obstet.
155 (Suppl 1):S45–S60. 2021. View Article : Google Scholar
|
|
6
|
Colombo N, Creutzberg C, Amant F, Bosse T,
González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza
MR, et al: ESMO-ESGO-ESTRO consensus conference on endometrial
cancer: Diagnosis, treatment and follow-up. Ann Oncol. 27:16–41.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reijnen C, Visser NC, Kasius JC, Boll D,
Geomini PM, Ngo H, Van Hamont D, Pijlman BM, Vos MC, Bulten J, et
al: Improved preoperative risk stratification with CA-125 in
low-grade endometrial cancer: A multicenter prospective cohort
study. J Gynecol Oncol. 30:e702019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin Q: Application value of Ki67 and serum
CA125 in the deep myometrial invasion of endometrial
adenocarcinoma. BMC Cancer. 23:2402023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang P and Yuan R: Analysis of factors
related to lymph node metastasis in early-stage type 1 endometrial
cancer: Verifying the clinical value of positive threshold of the
IHC parameter Ki67. Cancer Manag Res. 13:6319–6328. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong JH, Huang DH and Chen ZY: Prognostic
role of systemic immune-inflammation index in solid tumors: A
systematic review and meta-analysis. Oncotarget. 8:75381–75388.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huo D and Yang L: Significance of the
neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, and
platelet-lymphocyte ratio in peripheral blood for endometrial
cancer. Am J Transl Res. 16:6689–6698. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshida H, Takigawa W, Kobayashi-Kato M,
Nishikawa T, Shiraishi K and Ishikawa M: Mismatch repair protein
expression in endometrial cancer: Assessing concordance and
unveiling pitfalls in two different immunohistochemistry assays. J
Pers Med. 13:12602023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33.
2022.PubMed/NCBI
|
|
14
|
Crosbie EJ, Kitson SJ, McAlpine JN,
Mukhopadhyay A, Powell ME and Singh N: Endometrial cancer. Lancet.
399:1412–1428. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salinas-Vera YM, Gallardo-Rincón D,
Ruíz-García E, Silva-Cázares MB, De la Peña-Cruz SC and
López-Camarillo C: The role of hypoxia in endometrial cancer. Curr
Pharm Biotechnol. 23:221–234. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu KH and Broaddus RR: Endometrial Cancer.
N Engl J Med. 2020 Nov 19;383:2053–2064. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tu H, Huang H, Xian B, Li J, Wang P, Zhao
W, Chen X, Xie X, Wang C, Kong B, et al: Sentinel lymph node biopsy
versus pelvic lymphadenectomy in early-stage cervical cancer: A
multi-center randomized trial (PHENIX/CSEM 010). Int J Gynecol
Cancer. 30:1829–1833. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ørtoft G, Lausten-Thomsen L, Høgdall C,
Hansen ES and Dueholm M: Lymph-vascular space invasion (LVSI) as a
strong and independent predictor for non-locoregional recurrences
in endometrial cancer: A Danish Gynecological Cancer Group Study. J
Gynecol Oncol. 30:e842019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song J, Le T, Hopkins L, Fung-Kee-Fung M,
Jooya A, Lupe K, Gaudet M and Samant R: Treatment of early stage
highrisk endometrioid-type endometrial cancer and patterns of
disease relapse: A retrospective analysis. Adv Radiat Oncol.
5:910–919. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Boer SM, Nout RA, Bosse T and
Creutzberg CL: Adjuvant therapy for high-risk endometrial cancer:
Recent evidence and future directions. Expert Rev Anticancer Ther.
19:51–60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai Y, Wang B, Xu W, Liu K, Gao Y, Guo C,
Chen J, Kamal MA and Yuan C: Endometrial cancer: Genetic, metabolic
characteristics, therapeutic strategies and nanomedicine. Curr Med
Chem. 28:8755–8781. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barben J, Kamga MA, Guilloteau A, Quipourt
V, Bengrine-Lefevre L and Dabakuyo-Yonli TS: Are older women with
early-stage endometrial cancer undertreated and more likely to die
from their cancer? Maturitas. 202:1087412025. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vuppu PD, Rajanbabu A, Bhati P, Nair IR,
Nair AS and Pavithran K: Beyond the number-age as a prognostic
indicator in endometrial cancer. Eur J Obstet Gynecol Reprod Biol.
314:1146642025. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhai L, Cheng Y, Wu M, Wang T, Yin M, Yang
X, Sun B, Li C, He M, Sun Y, et al: Metabolic syndrome promotes
endometrial cancer by Oleic acid-mediated polyamine accumulation.
Nat Commun. 17:3882025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu Z, Hu Z, Li Q, Liu G, Oaknin A, Grau
Bejar JF, Mills GB, Ma D, Sun C and Chen G: Molecular and clinical
insights into early-onset endometrial cancer. Trends Cancer.
11:503–519. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu K, Huang ZY, Xu XL, Li J, Fu XW and
Deng SL: Estrogen receptor function:Impact on the human
endometrium. Front Endocrinol (Lausanne). 13:8277242022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Husby A, Wohlfahrt J and Melbye M:
Pregnancy duration and endometrial cancer risk: Nationwide cohort
study. BMJ. 366:l46932019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jordan SJ, Na R, Weiderpass E, Adami HO,
Anderson KE, van den Brandt PA, Brinton LA, Chen C, Cook LS,
Doherty JA, et al: Pregnancy outcomes and risk of endometrial
cancer: A pooled analysis of individual participant data in the
Epidemiology of Endometrial Cancer Consortium. Int J Cancer.
148:2068–2078. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schüler-Toprak S, Skrzypczak M, Gründker
C, Ortmann O and Treeck O: Role of estrogen receptor β, G-Protein
coupled estrogen receptor and estrogen-related receptors in
endometrial and ovarian cancer. Cancers (Basel). 15:28452023.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei L, Shi C and Zhang Y: Expression of
miR-34a and Ki67 in nasopharyngeal carcinoma and the relationship
with clinicopathological features and prognosis. Oncol Lett.
19:1273–1280. 2020.PubMed/NCBI
|
|
31
|
Clarke MA, Devesa SS, Harvey SV and
Wentzensen N: Hysterectomy-corrected uterine corpus cancer
incidence trends and differences in relative survival reveal racial
disparities and rising rates of nonendometrioid cancers. J Clin
Oncol. 37:1895–1908. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Andrés-Sánchez N, Fisher D and Krasinska
L: Physiological functions and roles in cancer of the proliferation
marker Ki-67. J Cell Sci. 135:jcs2589322022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding SX, Sun YF, Meng H, Wang JN, Xue LY,
Gao BL and Yin XP: Radiomics model based on multi-sequence MRI for
preoperative prediction of ki-67 expression levels in early
endometrial cancer. Sci Rep. 13:220522023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Refaat L, Eissa MS, Elnaggar GN, Mehesen
M, Eissa MS, Kamal A and Abdellateif MS: Systemic inflammatory
indices comprising monocytes provide a clinical significance for
thyroid cancer identification. Sci Rep. 15:399672025. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eo WK, Kwon S, Koh SB, Kim MJ, Ji YI, Lee
JY, Suh DS, Kim KH and Kim HY: The lymphocyte-monocyte ratio
predicts patient survival and aggressiveness of endometrial cancer.
J Cancer. 7:538–545. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin H, Zhong W, Zhong L, Que C and Lin X:
The inflammatory markers combined with CA125 may predict
postoperative survival in endometrial cancer. J Obstet Gynaecol.
44:23739372024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jin W, Yin H, Li H, Yu XJ, Xu HX and Liu
L: Neutrophil extracellular DNA traps promote pancreatic cancer
cells migration and invasion by activating EGFR/ERK pathway. J Cell
Mol Med. 25:5443–5456. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kennel KB, Bozlar M, De Valk AF and Greten
FR: Cancer-Associated fibroblasts in inflammation and antitumor
immunity. Clin Cancer Res. 29:1009–1016. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Paijens ST, Vledder A, de Bruyn M and
Nijman HW: Tumor-infiltrating lymphocytes in the immunotherapy era.
Cell Mol Immunol. 18:842–859. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qiu XP, Xie RY, Chen Y, Tu M and Wang T:
Clinical value of lymphocyte count in risk prediction of papillary
thyroid carcinoma: A case-control study in a Chinese population. J
Inflamm Res. 18:12971–12988. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lesokhin AM, Hohl TM, Kitano S, Cortez C,
Hirschhorn-Cymerman D, Avogadri F, Rizzuto GA, Lazarus JJ, Pamer
EG, Houghton AN, et al: Monocytic CCR2(+) myeloid-derived
suppressor cells promote immune escape by limiting activated CD8
T-cell infiltration into the tumor microenvironment. Cancer Res.
72:876–886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Doshi C, Zahir M, Dadabhoy A, Escobar D,
Xia L and Daneshmand S: Serum tumor markers for muscle-invasive
bladder cancer in clinical practice: A narrative review. Cancers
(Basel). 17:7282025. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wakefield C and Hornick JL: Update on
immunohistochemistry in bone and soft tissue tumors:
Cost-effectively replacing molecular testing with
immunohistochemistry. Hum Pathol. 147:58–71. 2024. View Article : Google Scholar : PubMed/NCBI
|
